carboplatin
Showing 1 - 25 of 1,824
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)
Not yet recruiting
- Recurrent Ovarian Cancer
- +3 more
- RP-6306
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 25, 2023
Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)
Not yet recruiting
- Prostate Cancer
- ADI-PEG 20
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 16, 2023
Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)
Not yet recruiting
- Recurrent Ovarian Cancer
- CPI-0209
- carboplatin
-
Pittsburgh, PennsylvaniaMagee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023
Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)
Recruiting
- Advanced Solid Tumors
- Debio 0123
- Carboplatin
-
Groningen, Netherlands
- +3 more
Jan 27, 2023
Ovarian Cancer Trial in San Diego (VS-6063, Paclitaxel, Carboplatin)
Recruiting
- Ovarian Cancer
- VS-6063
- +2 more
-
San Diego, CaliforniaUniversity of California San Diego
Feb 1, 2023
Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)
Not yet recruiting
- Metastatic Triple-Negative Breast Cancer
- Trilaciclib
- +3 more
-
Charlotte, North CarolinaLevine Cancer Institute
Aug 31, 2023
Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom
Active, not recruiting
- Triple Negative Metastatic Breast Cancer
- +3 more
- KU-0059436 (AZD2281)(PARP inhibitor)
- +3 more
-
Brussels, Belgium
- +3 more
Dec 19, 2022
NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
- Atezolizumab
- +5 more
- (no location specified)
Jan 18, 2023
Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)
Active, not recruiting
- Adult Solid Neoplasm
- Carboplatin
- +4 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 25, 2023
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Carboplatin
- Tocilizumab
-
Carmel, Indiana
- +2 more
Apr 27, 2023
Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)
Active, not recruiting
- Lung Cancer
- Carboplatin
- +2 more
-
Tampa, Florida
- +1 more
Feb 2, 2023
Lung Cancer Trial in Carlsbad, Cleveland (ISIS 3521, carboplatin, paclitaxel)
Completed
- Lung Cancer
- ISIS 3521
- +2 more
-
Carlsbad, California
- +1 more
Dec 1, 2022
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)
Completed
- BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
- Doxorubicin
- +3 more
-
Barretos, SP, BrazilBarretos Cancer Hospital
Dec 25, 2022
Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)
Not yet recruiting
- Prostate Cancer Metastatic
- Pembrolizumab
- +2 more
- (no location specified)
Sep 29, 2022
Breast Cancer Trial in Tampa (Eribulin, Carboplatin)
Completed
- Breast Cancer
- Eribulin
- Carboplatin
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Oct 28, 2022
NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tiragolumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 16, 2023
Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- Nivolumab
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Efficacy and Safety Trial in Zhejiang (pegylated liposomal doxorubicin, paclitaxel, Carboplatin)
Active, not recruiting
- Efficacy and Safety
- pegylated liposomal doxorubicin
- +2 more
-
Zhejiang, Hangzhou, ChinaWomen's Hospital School Of Medicine Zhejiang University
Jul 14, 2022
Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer Recurrent
- Debio 0123
- +2 more
-
Madrid, Spain
- +3 more
Apr 3, 2023
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)
Not yet recruiting
- Glioblastoma
- +2 more
- SonoCloud-9 (SC9)
- +3 more
-
Chicago, Illinois
- +7 more
Jun 5, 2023
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- KAND567
- Carboplatin
-
Odense, Denmark
- +3 more
Oct 16, 2023
NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Bevacizumab
- +2 more
-
Arkhangel'sk, Russian Federation
- +10 more
Dec 8, 2022
Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)
Active, not recruiting
- Advanced Cancer
- Temsirolimus
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022